Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,630 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials.
Hsu EJ, Lin TA, Dabush DR, McCaw Z, Koong A, Lin C, Abi Jaoude J, Patel R, Kouzy R, El Alam MB, Noticewala S, Yang Y, Sherry AD, Fuller CD, Thomas CR Jr, Tang C, Msaouel P, Das P, Huang B, Tian L, Sun R, Lee JJ, Meirson T, Ludmir EB. Hsu EJ, et al. Among authors: patel r. J Natl Cancer Inst. 2024 Feb 9:djae028. doi: 10.1093/jnci/djae028. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 38331394
Food and Drug Administration approvals in phase 3 Cancer clinical trials.
Abi Jaoude J, Kouzy R, Ghabach M, Patel R, Pasalic D, Ghossain E, Miller AB, Lin TA, Verma V, Fuller CD, Subbiah V, Minsky BD, Ludmir EB, Taniguchi CM. Abi Jaoude J, et al. Among authors: patel r. BMC Cancer. 2021 Jun 12;21(1):695. doi: 10.1186/s12885-021-08457-5. BMC Cancer. 2021. PMID: 34118915 Free PMC article. Clinical Trial.
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials.
Florez MA, Jaoude JA, Patel RR, Kouzy R, Lin TA, De B, Beck EJ, Taniguchi CM, Minsky BD, Fuller CD, Lee JJ, Kupferman M, Raghav KP, Overman MJ, Thomas CR Jr, Ludmir EB. Florez MA, et al. Among authors: patel rr. JAMA Netw Open. 2023 May 1;6(5):e2313819. doi: 10.1001/jamanetworkopen.2023.13819. JAMA Netw Open. 2023. PMID: 37195664 Free PMC article. Clinical Trial.
Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy.
Sherry AD, Msaouel P, McCaw ZR, Abi Jaoude J, Hsu EJ, Kouzy R, Patel R, Yang Y, Lin TA, Taniguchi CM, Rödel C, Fokas E, Tang C, Fuller CD, Minsky B, Meirson T, Sun R, Ludmir EB. Sherry AD, et al. Among authors: patel r. Eur J Cancer. 2023 Nov;194:113357. doi: 10.1016/j.ejca.2023.113357. Epub 2023 Sep 22. Eur J Cancer. 2023. PMID: 37827064 Free article.
Impact factor and citation metrics in phase III cancer trials.
Abi Jaoude J, Kouzy R, Rooney M, Thompson P, Patel R, Turner MC, Ghabach M, Fuller CD, Minsky BD, Taniguchi CM, Ludmir EB. Abi Jaoude J, et al. Among authors: patel r. Oncotarget. 2021 Aug 31;12(18):1780-1786. doi: 10.18632/oncotarget.28044. eCollection 2021 Aug 31. Oncotarget. 2021. PMID: 34504650 Free PMC article.
Inclusion of premenopausal women in breast cancer clinical trials.
Corrigan KL, Kouzy R, Jaoude JA, Patel RR, Layman RM, Giordano SH, Woodward WA, Smith BD, Shaitelman SF, Ludmir EB. Corrigan KL, et al. Among authors: patel rr. Breast. 2022 Dec;66:204-207. doi: 10.1016/j.breast.2022.10.013. Epub 2022 Oct 26. Breast. 2022. PMID: 36327626 Free PMC article.
Exclusion of patients with brain metastases from cancer clinical trials.
Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, de Groot JF, Mandel JJ, Ludmir EB. Patel RR, et al. Neuro Oncol. 2020 Apr 15;22(4):577-579. doi: 10.1093/neuonc/noz246. Neuro Oncol. 2020. PMID: 31900480 Free PMC article. No abstract available.
9,630 results